Koppikar Utpal 4
4 · Atara Biotherapeutics, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-05-17$5.32/sh−4,616$24,539→ 208,558 total - Sale
Common Stock
2022-05-17$5.32/sh−966$5,136→ 207,592 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 17, 2022 and May 18, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.